Is Advanced Therapies Europe Worth Attending?
Whether you're a biotech executive, scientist, investor, manufacturer, CDMO, technology provider, or healthcare leader, hear first-hand why industry professionals chose to attend and what value they gained from three days of networking, partnering, and knowledge-sharing in Barcelona.
Why Europe? Why now?
Europe is at a defining moment in advanced therapies.
The science is proven. The pipeline is maturing. But commercial success remains the hardest part.
Fragmented regulation, inconsistent market access, and reimbursement complexity are holding the continent back. Not for lack of innovation, but lack of alignment.
Advanced Therapies Europe exists to change that.
Three days. The leaders, investors, and innovators who are actually moving the needle. Targeted content, curated networking, and high-value connections. Built specifically for the European CGT landscape.
Download the Delegate Pack
Everything you need to know about Advanced Therapies Europe 2026 in one place.
Inside the delegate pack:
- A breakdown of attending investors, pharma, and biotech companies
- Insight into the types of deals, partnerships, and conversations happening
- How the 1:1 meeting concierge works and how you’re matched
- An overview of the agenda, themes, and key discussion area